International Clinical Trial: Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES

Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07121439) titled 'Efficacy and Safety of a Combined Serum Containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Investigator).

Primary Sponsor: Dr.dr.Irma Bernadette, SpKK (K)

Condition: Melasma Post-acne Hyperpigmentation

Intervention: Drug: a combination serum containing Melasyl™, 10% Niacinamide, Hyaluronic Acid, and HEPES

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 15, 2025

Target Sample Size: 68 ...